- Home
- / GCANRx
GCANRx
Revenue
$12.6 K
FY, 2021
GCANRx Summary
Company Summary
- Overview
- GCANRx (The Greater Cannabis Company) is a biopharmaceutical company that is focused on the development and commercialization of cannabinoid delivery systems. Its focus is on commercializing technology developed by Pharmedica for transmucosal delivery of legal medical or recreational cannabis and cannabinoids.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Pikesville, MD, US | view all locations
- Website
- https://www.gcanrx.com/
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
1 location detected
Pikesville, MD HQ
United States
15 Walker Ave #101
GCANRx Financials
Summary Financials
- Net income (Q1, 2026)
- ($33.4K)
- Cash (Q1, 2026)
- $1.4K
- EBIT (Q1, 2026)
- ($33.4K)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026